CIRAX | GBLAX | CIRAX / GBLAX | |
Total Expense Ratio | 0.62 | 0.81 | 77% |
Annual Report Gross Expense Ratio | 0.62 | 0.81 | 77% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 9.831 | 7.003 | 140% |
Front Load | 4% | 6% | 61% |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 113B | 27.1B | 417% |
Annual Yield % from dividends | 3.02 | 1.91 | 158% |
Returns for 1 year | 13.01 | 5.05 | 258% |
Returns for 3 years | 23.74 | 18.08 | 131% |
Returns for 5 years | 49.33 | 22.15 | 223% |
Returns for 10 years | 76.82 | 38.41 | 200% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQH | 15.69 | 0.28 | +1.82% |
abrdn Healthcare Investors | |||
CDEI | 72.53 | 1.21 | +1.70% |
Calvert US Large-Cp Div, Eq AndIncETF | |||
IZRL | 24.90 | 0.25 | +1.01% |
ARK Israel Innovative Technology ETF | |||
ESGV | 106.10 | 1.03 | +0.98% |
Vanguard ESG US Stock ETF | |||
NJAN | 49.60 | 0.20 | +0.40% |
Innovator Growth-100 Pwr Buff ETF™ Jan |